Changing the Future of Cancer Care: Skin Cancer
The skin cancer specialists at Miami Cancer Institute’s Multidisciplinary Skin Cancer Clinic combine the expertise of many medical disciplines to provide you with the most comprehensive approach to screening, diagnosing and treating skin cancer. Our multidisciplinary team uses innovative technology to detect skin cancer at its earliest phase and advanced techniques for treating your specific type of skin cancer. This multidisciplinary and individualized approach leads to effective cancer treatment.
Skin cancer, the general term used when malignant (cancerous) cells form within the tissues of the skin, is the most common type of cancer. It can be found anywhere in the body, but it’s usually found on the parts of the body most exposed to sunlight, like the head, face, neck and hands. While people with light skin, hair and eyes have a higher risk for sun-related skin cancers, there are risk factors for those of Hispanic, African-American and other descents, also.
There are many types of skin cancer, each with specific risk factors, symptoms, prevention techniques and treatments. As a result, prognosis and treatment options vary based on each person’s own genetic makeup, location of the cancer cells and stage of the cancer.
Our multidisciplinary team gathers information using the latest skin cancer monitoring and detection tools, such as Vectra 3D Whole Body Photo-Imaging and Reflectance Confocal Microscopy (RCM), a non-invasive imaging technique that uses a low-power laser, without radiation or harm to the skin, to determine whether a skin lesion needs to be biopsied, to create a personalized treatment plan for you. The team incorporates groundbreaking discoveries and collaborates with other world-renowned cancer researchers to deliver the most effective and comprehensive treatment available.
Rare Skin Cancers
The skin cancer specialists at Miami Cancer Institute’s Multidisciplinary Skin Cancer Clinic also treat rare skin cancers including: Adnexal tumors (Sebaceous carcinoma, pilomatrix carcinoma, porocarcinoma, digital papillary adenocarcinoma), Atypical fibroxanthoma and Kaposi sarcoma.
1 in 5
A multidisciplinary team of cancer experts including surgeons, medical oncologists, radiation oncologists, plastic reconstructive surgeons, pathologists, radiologists, genetic counselors, medical geneticists, social workers, patient navigators and clinical trials staff meet weekly to discuss select complex cases and determine the best course of care. Hematologic oncology experts are also available to discuss complex cases.